ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 2.33% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Dec 24
- DEBTORS TURNOVER RATIO(HY) Lowest at 4.38%
3
With ROE of 7.64%, it has a Very Expensive valuation with a 0.24 Price to Book Value
- Over the past year, while the stock has generated a return of 54.67%, its profits have risen by 15.1% ; the PEG ratio of the company is 0.2
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Fosun Pharmaceutical (Group) Co., Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
54.67%
1.41
42.64%
Hang Seng Hong Kong
27.36%
1.06
25.88%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.60%
EBIT Growth (5y)
2.33%
EBIT to Interest (avg)
2.29
Debt to EBITDA (avg)
2.95
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
0.54
Tax Ratio
26.00%
Dividend Payout Ratio
31.12%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.16%
ROE (avg)
9.03%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
0.24
EV to EBIT
10.52
EV to EBITDA
4.81
EV to Capital Employed
0.44
EV to Sales
0.69
PEG Ratio
0.21
Dividend Yield
NA
ROCE (Latest)
4.21%
ROE (Latest)
7.64%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Pre-Tax Profit
At HKD 1,595.41 MM has Grown at 812.9%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (HKD MM)
Pre-Tax Profit
Highest at HKD 1,595.41 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD 1,706.91 MM has Grown at 65.42%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Depreciation
Highest at HKD 1,798.29 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 1,798.29 MM has Grown at 9.66%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Debtors Turnover Ratio
Lowest at 4.38%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Non Operating Income
Highest at HKD 0.79 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
